Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

2.3K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.3K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

1.3K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.3K
Neural Regulation01:37

Neural Regulation

44.7K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
44.7K
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

4.7K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

rAAV Fbxo7 gene therapy rescues the progressive nigrostriatal pathology in a mouse model of juvenile parkinsonism.

Acta neuropathologica communications·2026
Same author

Capivasertib Combines with Trastuzumab Deruxtecan to Enhance Antitumor Activity in HER2-Positive and HER2-Low Tumors.

Molecular cancer therapeutics·2026
Same author

CD33 and clusterin interact biophysically and genetically to modulate Alzheimer risk.

bioRxiv : the preprint server for biology·2025
Same author

Retraction Notice to: A FBXO7/EYA2-SCF<sup>FBXW7</sup> axis promotes AXL-mediated maintenance of mesenchymal and immune evasion phenotypes of cancer cells.

Molecular cell·2024
Same author

Study of an FBXO7 patient mutation reveals Fbxo7 and PI31 co-regulate proteasomes and mitochondria.

The FEBS journal·2024
Same author

Editorial: E3 ubiquitin ligases: From structure to physiology to therapeutics, Volume II.

Frontiers in physiology·2022

Related Experiment Video

Updated: Mar 24, 2026

The Use of Primary Human Fibroblasts for Monitoring Mitochondrial Phenotypes in the Field of Parkinson's Disease
15:09

The Use of Primary Human Fibroblasts for Monitoring Mitochondrial Phenotypes in the Field of Parkinson's Disease

Published on: October 3, 2012

17.5K

Structure and Function of Fbxo7/PARK15 in Parkinson's Disease.

Suzanne J Randle1, Heike Laman1

  • 1Department of Pathology, University of Cambridge, Tennis Court Road, Cambridge CB2 1QP, United Kingdom.

Current Protein & Peptide Science
|March 12, 2016
PubMed
Summary

Mutations in the Fbxo7 protein are linked to early-onset Parkinson's disease (PD). Understanding how these mutations affect Fbxo7's function is crucial for PD pathogenesis research.

Keywords:
E3 ligaseF-box proteinFbxo7/PARK15Parkinson's diseaseSCF-ligasemitophagyubiquitin

More Related Videos

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
06:07

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease

Published on: June 23, 2023

2.4K
Gait Analysis of Age-dependent Motor Impairments in Mice with Neurodegeneration
07:46

Gait Analysis of Age-dependent Motor Impairments in Mice with Neurodegeneration

Published on: June 18, 2018

12.7K

Related Experiment Videos

Last Updated: Mar 24, 2026

The Use of Primary Human Fibroblasts for Monitoring Mitochondrial Phenotypes in the Field of Parkinson's Disease
15:09

The Use of Primary Human Fibroblasts for Monitoring Mitochondrial Phenotypes in the Field of Parkinson's Disease

Published on: October 3, 2012

17.5K
Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
06:07

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease

Published on: June 23, 2023

2.4K
Gait Analysis of Age-dependent Motor Impairments in Mice with Neurodegeneration
07:46

Gait Analysis of Age-dependent Motor Impairments in Mice with Neurodegeneration

Published on: June 18, 2018

12.7K

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Genetics

Background:

  • Fbxo7, also known as PARK15, functions as an E3 ubiquitin ligase within the Skp1-Cul1-F box protein (SCF) complex.
  • SCF-independent activities of Fbxo7 are also recognized.
  • Mutations in the FBXO7 gene are associated with early-onset Parkinson's disease (PD).

Purpose of the Study:

  • To review recent advances in understanding Fbxo7 function in Parkinson's disease.
  • To correlate the location of FBXO7 mutations with protein domains and their impact on function.
  • To hypothesize the contribution of Fbxo7 functions to PD pathogenesis.

Main Methods:

  • Literature review of studies on Fbxo7 and Parkinson's disease.
  • Analysis of mutation data within the context of Fbxo7 functional domains (F-box domain, proline-rich region, ubiquitin-like domain).

Main Results:

  • Mutations causing early-onset PD are located within or near critical functional domains of Fbxo7.
  • Specific domains affected include the F-box domain (FBD), proline-rich region (PRR), and ubiquitin-like domain (Ubl).

Conclusions:

  • Fbxo7 plays a significant role in the pathogenesis of Parkinson's disease.
  • The localization of mutations within specific functional domains provides insights into Fbxo7's role in PD.
  • Further research into Fbxo7's diverse functions is warranted to elucidate its comprehensive role in PD.